Dioxacarb
CAS: 6988-21-2
Ref. 3D-GAA98821
1g | Discontinued | ||
25mg | Discontinued | ||
50mg | Discontinued | ||
100mg | Discontinued | ||
250mg | Discontinued | ||
500mg | Discontinued |
Product Information
- 2-(1,3-Dioxolan-2-Yl)Phenyl Methylcarbamate
- 2-(1,3-Dioxolan-2-yl)phenyl N-methylcarbamate
- 2-(1,3-Dioxolane-2-yl)-phenyl N-methylcarbamate
- C 8353
- Carbamic acid, methyl-, o-1,3-dioxolan-2-ylphenyl ester
- Ciba 8353
- Ciba C 8353
- Du Pont 1519
- Elocron
- Elocron 50WP
- See more synonyms
- Elocron 8353
- Famid
- Phenol, 2-(1,3-dioxolan-2-yl)-, 1-(N-methylcarbamate)
- Phenol, 2-(1,3-dioxolan-2-yl)-, methylcarbamate
- Rovlinka
- o-(1,3-Dioxolan-2-yl)phenyl methylcarbamate
Dioxacarb is an anticancer drug that acts as a kinase inhibitor. It works by inhibiting the activity of specific kinases, which are enzymes that play a crucial role in cancer cell growth and proliferation. Dioxacarb contains indirubin, an analog of a protein kinase inhibitor found in Chinese herbal medicine. This drug has been shown to induce apoptosis (programmed cell death) in human cancer cells and inhibit tumor growth in animal models. Dioxacarb also has potential use as a diagnostic tool for detecting cancer, as it can be detected in urine samples from cancer patients. Overall, Dioxacarb shows promise as an effective anticancer therapy with few side effects.